Literature DB >> 23357099

Protective effect of galantamine against oxidative damage using human lymphocytes: a novel in vitro model.

Luz Elena Triana-Vidal1, Silvio Marino Carvajal-Varona.   

Abstract

BACKGROUND AND AIMS: Neurodegenerative disorders such as Alzheimer's disease are characterized in the initial stages by an increase in reactive oxygen species that trigger apoptosis or programmed cell death. It has been suggested that the synthetic alkaloid galantamine may offer protection against this cell loss. This investigation sought to assess the protective effect of galantamine against oxidative damage induced by hydrogen peroxide (H2O2) using human lymphocytes cultured in vitro as a model.
METHODS: Cell death can be measured indirectly using cell viability testing with trypan blue. Determination of the galantamine concentrations used was made possible by the negative correlation found between galantamine concentration and average mitotic index (MI).
RESULTS: Average viability of lymphocytes treated with low and medium concentrations of galantamine was significantly higher than the control.
CONCLUSION: Galantamine does indeed demonstrate a protective capacity against cell damage induced by hydrogen peroxide. This finding supports the possible use of the drug in treatment of neurodegenerative diseases related to oxidative stress.
Copyright © 2013 IMSS. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23357099     DOI: 10.1016/j.arcmed.2013.01.001

Source DB:  PubMed          Journal:  Arch Med Res        ISSN: 0188-4409            Impact factor:   2.235


  7 in total

1.  Antibacterial, Anticancer and Neuroprotective Activities of Rare Actinobacteria from Mangrove Forest Soils.

Authors:  Adzzie-Shazleen Azman; Iekhsan Othman; Chee-Mun Fang; Kok-Gan Chan; Bey-Hing Goh; Learn-Han Lee
Journal:  Indian J Microbiol       Date:  2016-10-26       Impact factor: 2.461

Review 2.  Neuroprotective Effects of Cholinesterase Inhibitors: Current Scenario in Therapies for Alzheimer's Disease and Future Perspectives.

Authors:  Natália Chermont Dos Santos Moreira; Jéssica Ellen Barbosa de Freitas Lima; Marcelo Fiori Marchiori; Ivone Carvalho; Elza Tiemi Sakamoto-Hojo
Journal:  J Alzheimers Dis Rep       Date:  2022-04-18

3.  Mitigation of ROS insults by Streptomyces secondary metabolites in primary cortical neurons.

Authors:  Marta Leirós; Eva Alonso; Jon A Sanchez; Mostafa E Rateb; Rainer Ebel; Wael E Houssen; Marcel Jaspars; Amparo Alfonso; Luis M Botana
Journal:  ACS Chem Neurosci       Date:  2013-11-19       Impact factor: 4.418

4.  Galantamine-Memantine Combination as an Antioxidant Treatment for Schizophrenia.

Authors:  Maju Mathew Koola; Samir Kumar Praharaj; Anilkumar Pillai
Journal:  Curr Behav Neurosci Rep       Date:  2019-05-17

Review 5.  Does kynurenic acid act on nicotinic receptors? An assessment of the evidence.

Authors:  Trevor W Stone
Journal:  J Neurochem       Date:  2019-11-24       Impact factor: 5.372

6.  Spongionella secondary metabolites protect mitochondrial function in cortical neurons against oxidative stress.

Authors:  Marta Leirós; Jon A Sánchez; Eva Alonso; Mostafa E Rateb; Wael E Houssen; Rainer Ebel; Marcel Jaspars; Amparo Alfonso; Luis M Botana
Journal:  Mar Drugs       Date:  2014-01-27       Impact factor: 5.118

7.  Streptomyces antioxidans sp. nov., a Novel Mangrove Soil Actinobacterium with Antioxidative and Neuroprotective Potentials.

Authors:  Hooi-Leng Ser; Loh Teng-Hern Tan; Uma D Palanisamy; Sri N Abd Malek; Wai-Fong Yin; Kok-Gan Chan; Bey-Hing Goh; Learn-Han Lee
Journal:  Front Microbiol       Date:  2016-06-16       Impact factor: 5.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.